New nebulizer technology to monitor adherence and nebulizer performance in Cystic Fibrosis

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 25, Issue 6, 2012, Pages 307-309

  Mccormack, Pamela ^a   Southern, Kevin W ^a   Mcnamara, Paul S ^a  

^a ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN;

AEROSOL; ANTIBIOTIC THERAPY; CYSTIC FIBROSIS; ERADICATION THERAPY; FEEDBACK SYSTEM; HUMAN; INFECTION; LONG TERM CARE; LUNG FIBROSIS; LUNG FUNCTION; NEBULIZER; PATIENT COMPLIANCE; PEDIATRIC HOSPITAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; REVIEW;

ADMINISTRATION, INHALATION; AEROSOLS; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HUMANS; INFLAMMATION; MEDICATION ADHERENCE; NEBULIZERS AND VAPORIZERS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84870474621     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2011.0934     Document Type: Review

References (10)

1. Smyth AR, Barbato A, Beydon N, Bisgaard H, de Boeck K, Brand P, Bush A, Fauroux B, de Jongste J,Korppi M, O'Callaghan C, Pijnenburg M, Ratjen F, Southern K, Spencer D, Thompson A, Vyas H, Warris A, and Merkus PJ: Respiratory medicines for children: Current evidence, unlicensed use and research priorities. Eur Respir J. 2010:35:247-265.
2. Haynes RB: Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008:16.
3. Kesser KC, and Geller DE: New aerosol delivery devices for cystic fibrosis. Respir Care. 2009;54:754-768.
4. Denyer J, Nikander K, and Smith NJ: Adaptive Aerosol Delivery (AAD) technology. Expert opinion on drug delivery. ;1:165-176.
5. McNamara PS, McCormack P, McDonald AJ, Heaf L, and Southern KW: Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosis. J Cyst Fibros. ;8:258-263.
6. McCormack P, McDonald AJ, Heaf L, Southern KW, and McNamara PS: Adherence to nebulised therapies for Pseudomonas eradication in a paediatric CF population. J Cyst Fibros. 2008;7(Suppl 2):p64.
7. Denyer J, and Dyche T: The Adaptive Aerosol Delivery (AAD) technology: Past, present, and future. J Aerosol Med Pulmon Drug Deliv. 2010;23(Suppl 1):S1-S10.
8. Nikander K, Prince I, Coughlin S, Warren S, and Taylor G: Mode of breathing-tidal or slow and deep-through the I-neb Adaptive Aerosol Delivery (AAD) system affects lung deposition of (99m)Tc-DTPA. J Aerosol Med Pulmon Drug Deliv. 2010;23(Suppl 1):S37-S43.
9. Denyer J, Prince I, Dixon E, Agent P, Pryor J, and Hodson M: Evaluation of the Target Inhalation Mode (TIM) breathing maneuver in simulated nebulizer therapy in patients with cystic fibrosis. J Aerosol Med Pulmon Drug Deliv. 2010; 23(Suppl 1):S29-S36.
10. McCormack P, McNamara PS, and Southern KW. A randomised controlled trial of breathing modes for adaptive aerosol delivery in children with cystic fibrosis. J Cyst Fibros. ;10:343-349.